COMP <GO>
BJDX vs IVF // REVENUE GROWTH (YOY)
Bluejay Diagnostics Inc. (NASDAQ) VS. INVO Fertility Inc. (NASDAQ) • 15-METRIC TALLY: BJDX 1
— IVF 2
■ METRIC PARITY
LAST: $0.54 (-5.08%) • MKT CAP: $2.4M
revenue-growth
—
LAST: $0.54 (-3.60%) • MKT CAP: $2.5M
revenue-growth
4.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BJDX VS. IVF)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BJDX | IVF | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 96.00% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | 68.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | — | 4.30% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 5/9 | -2.00 | IVF | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 29.6 | 26.0 | +3.60 | BJDX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.4M | $2.5M | -$52.7K | IVF | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BJDX REV | IVF REV | BJDX GROSS % | IVF GROSS % | BJDX FCF | IVF FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $6.8M | — | 98.0% | -$6.2M | -$7.1M |
| FY 2024 | $0 | $6.6M | — | 43.3% | -$8.1M | -$3.2M |
| FY 2023 | $0 | $3.0M | — | — | -$8.3M | -$4.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BJDX // BETA —
IVF // BETA —